64Cu-PSMA-BCH: a new radiotracer for delayed PET imaging of prostate cancer

被引：0
|
作者：
Teli Liu
Chen Liu
Zhongyi Zhang
Ning Zhang
Xiaoyi Guo
Lei Xia
Jinquan Jiang
Qing Xie
Kun Yan
Steven P. Rowe
Hua Zhu
Zhi Yang
机构：
[1] Peking University Cancer Hospital & Institute,Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education/Beijing), NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), D
[2] Peking University Cancer Hospital & Institute,Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Ultrasonography
[3] Peking University Cancer Hospital & Institute,Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Urology
[4] Johns Hopkins University School of Medicine,The James Buchanan Brady Urology Institute and Department of Urology, and The Russell H. Morgan, Department of Radiology and Radiological Science
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2021年 / 48卷
关键词：
Cu-PSMA; Prostate cancer; PET/CT; Delayed imaging; Targeted biopsies;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4508 / 4516
页数：8
相关论文
共 50 条
  • [31] PSMA PET in Prostate Cancer
    Jadvar, Hossein
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (08) : 1131 - 1132
  • [32] Alternatives to PSMA-ligands for PET imaging of prostate cancer
    Withofs, N.
    Hustinx, R.
    Morgat, C.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2023, 47 (05): : 281 - 290
  • [33] Standardized PSMA-PET Imaging of Advanced Prostate Cancer
    Seifert, R.
    Gafita, A.
    Telli, T.
    Voter, Andrew
    Herrmann, K.
    Pomper, Martin
    Hadaschik, B.
    Rowe, Steven P.
    Fendler, W. P.
    SEMINARS IN NUCLEAR MEDICINE, 2024, 54 (01) : 60 - 68
  • [34] Role of PSMA PET/CT in imaging and management of prostate cancer
    El Hoyek, Nadine
    Shi, Xiaolei
    Jenkins, Jason
    Chen, Wengen
    CURRENT OPINION IN ONCOLOGY, 2025, 37 (03) : 233 - 239
  • [35] PET imaging in prostate cancer, future trends: PSMA ligands
    Fendler W.P.
    Bluemel C.
    Czernin J.
    Herrmann K.
    Clinical and Translational Imaging, 2016, 4 (6) : 467 - 472
  • [36] Synthesis and in vivo characterization of a heterobivalent radiotracer targeting PSMA and GRPR for prostate cancer imaging
    Bailly, Thibaud
    Prignon, Aurelie
    Morgat, Clement
    Goncalves, Victor
    Denat, Franck
    Valverde, Ibai
    NUCLEAR MEDICINE AND BIOLOGY, 2022, 108 : S177 - S178
  • [37] 18F-fluciclovine PET or PSMA PET for prostate cancer imaging?
    Baris Turkbey
    Peter L. Choyke
    Nature Reviews Urology, 2020, 17 : 9 - 10
  • [38] A novel androgen-independent radiotracer with dual targeting of NTSR1 and PSMA for PET/CT imaging of prostate cancer
    Wang, Qiong
    Li, Zhongjing
    Huang, Yong
    Li, Chengze
    Li, Yiluo
    Peng, Yi
    Sheng, Zonghai
    Liang, Ying
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2025, 282
  • [39] Heterodimeric Radiotracer Targeting PSMA and GRPR for Imaging of Prostate Cancer: Optimisation of the Affinity towards PSMA by Linker Modification
    Lundmark, F.
    Abouzayed, A.
    Mitran, B.
    Rinne, S. S.
    Varasteh, Z.
    Larhed, M.
    Tolmachev, V.
    Rosenstrom, U.
    Orlova, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S370 - S371
  • [40] Comparison of 64Cu-DOTA-PSMA-3Q and 64Cu-NOTA-PSMA-3Q utilizing NOTA and DOTA as bifunctional chelators in prostate cancer: preclinical assessment and preliminary clinical PET/CT imaging
    Liu, Huanhuan
    Zhang, Xiaojun
    Zhang, Jingfeng
    Pan, Yue
    Wen, Hui
    Xu, Xiaodan
    Wu, Shina
    Wang, Yuan
    Zhang, Cong
    Ma, Guangyu
    Liu, Yachao
    Wang, Ruimin
    Zhang, Jinming
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2025,
12345